Class in Session: Today’s Concepts on Targeted and CAR T-Cell Therapies Across B-Cell Malignancies

Watch an on-demand Webcast and download slidesets from our HOPA 2020 symposium where expert faculty review key developments in targeted and CAR T-cell therapies for B-cell malignancies and share their perspectives on how pharmacists can safely and effectively apply these new practice-changing data into care plans for their patients.

Share

Program Content

Activities

New Tx in B-Cell
Class in Session: Today’s Concepts on Targeted and CAR T-Cell Therapies Across B-Cell Malignancies
Congratulations: You achieved a completion on 04/09/2022

Activities

B-cell Lymphoma Inhibitors
Small Molecule Inhibitor Landscape in Mature B-Cell Lymphomas: Current Status, Future Directions, and Clinical Considerations
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: March 12, 2020

Expires: March 11, 2021

B-cell Lymphoma: CAR T
Focus on Integrating CAR T-Cell Therapy Into the Management of Mature B-Cell Lymphoma
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: March 12, 2020

Expires: March 11, 2021

<i>EP</i>: B-Cell Malignancies
ExpressPoints: Today’s Concepts on Targeted and CAR T-Cell Therapies Across B-Cell Malignancies
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: March 24, 2020

Expires: March 23, 2021

Faculty

cover img faculity

Zahra Mahmoudjafari, PharmD, BCOP, DPLA

Clinical Pharmacy Manager, Blood and Marrow Transplant Program
Division of Hematological Malignancies and Cellular Therapeutics
PGY2 Oncology Residency Program Director
The University of Kansas Cancer Center
Westwood, Kansas

cover img faculity

Anthony Perissinotti, PharmD, BCOP

Hematology Clinical Pharmacist Specialist
Clinical Team Leader
, Hematology/Oncology
Adjunct Clinical Assistant Professor
University of Michigan, Michigan Medicine
Roger Cancer Center
Ann Arbor, Michigan

Provided by

ProCE Banner

Supporters

Supported by an educational grant from

AbbVie Inc.